Medical device and MedTech insights, news, tips and more

New Renewable Energy Agreements To Reduce Boston Scientific Carbon Footprint By Half

April 22, 2020

chelsea-WvusC5M-TM8-unsplash

Boston Scientific Corporation (NYSE: BSX) has signed a virtual power purchase agreement (VPPA) that represents the largest step the company has taken to achieve its goal of global carbon neutral manufacturing and distribution by 2030. The agreement, with Clearway Energy Group, will address the electricity load for the company’s U.S. operations, which represents 45 percent of the company’s total carbon footprint.

chelsea-WvusC5M-TM8-unsplash

“Building on more than a decade of work to reduce our carbon footprint, this 42 megawatt (MW) solar deal equates to approximately 120,000 megawatt hours of renewable electricity annually,” said Brad Sorenson, senior vice president, Manufacturing and Supply Chain. “As a result of the agreement, Boston Scientific will offset emissions equivalent to removing more than 34,000 passenger vehicles from the road, or the amount of electricity needed to power more than 18,000 homes each year.”

Boston Scientific operates more than 4 million square feet of independently certified green real estate around the world, including five sites with ISO certified energy management systems in Costa Rica and Ireland. Its global energy management system focuses on cutting energy use, converting to renewable energy resources instead of fossil fuels, and compensating with carbon offset projects where needed. Since 2009, the strategy has helped the company reduce greenhouse gas emissions by 76,000 metric tons.

In addition to the VPPA, Boston Scientific subscribed to a portion of a 12.9 MW community solar portfolio in Massachusetts, which serves to drive demand for renewable energy and increase access to local clean electricity across the state. The community solar project was also developed by Clearway Energy Group.

See Full Press Release: New Renewable Energy Agreements To Reduce Boston Scientific Carbon Footprint By Half


Written by: Boston Scientific


Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.